Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7172 in Combination With Antitumor Therapy in Advanced Pancreatic Cancer
NCT07806058Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7172 in pancreatic cancer (PC), sponsored by Hengrui. Started Oct 2026; status: recruiting.
02
Drugs
HRS-7172
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07806058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07806058.